{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:15:00Z","timestamp":1790680500226,"version":"4.1.0"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["023.008.010"],"award-info":[{"award-number":["023.008.010"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Network Quality Development GGZ","award":["P140018"],"award-info":[{"award-number":["P140018"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0205278","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T17:30:49Z","timestamp":1539624649000},"page":"e0205278","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4799-3041","authenticated-orcid":true,"given":"Margreet S. H.","family":"Wortman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joran","family":"Lokkerbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.","family":"van der Wouden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri\u00ebtte E.","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim C.","family":"olde Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(07)60159-7","article-title":"Management of functional somatic syndrome","volume":"369","author":"P Henningsen","year":"2007","journal-title":"Lancet"},{"key":"ref2","first-page":"231","article-title":"Beyond somatisation: a review of the understanding and treatment of medically unexplained physical symptoms (MUPS)","volume":"53","author":"C Burton","year":"2003","journal-title":"Br J Gen Pract"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00018","article-title":"\u201cUnexplained\u201d somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift?","volume":"134","author":"M Sharpe","year":"2001","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(98)08320-2","article-title":"Functional somatic syndromes: One or many?","volume":"354","author":"S Wessely","year":"1999","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","article-title":"Prevalence of fibromyalgia: a survey in five European countries","volume":"39","author":"J Branco","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2036.2004.01938.x","article-title":"Incidence of a clinical diagnosis of the irritable bowel syndrome in a united states population","volume":"19","author":"GR Locke","year":"2004","journal-title":"Alimentary Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/eurpub\/ckp113","article-title":"Fatigue and chronic fatigue syndrome-like complaints in the general population","volume":"20","author":"M Van \u2018t Leven","year":"2010","journal-title":"Eur J Pub Health"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.7326\/0003-4819-130-11-199906010-00016","article-title":"Functional somatic syndromes","volume":"130","author":"AJ Barsky","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpsychores.2015.05.004","article-title":"Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines","volume":"79","author":"ML Joustra","year":"2015","journal-title":"J Psychosom Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12875-017-0592-6","article-title":"\u201cMedically unexplained\u201dsymptoms and symptom disorders in primary care: prognosis-based recognition and classification","volume":"18","author":"M Rosendal","year":"2017","journal-title":"BMC Family Practice"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2296-8-33","article-title":"Patients with persistent medically unexplained symptoms in general practice: Characteristics and quality of care","volume":"8","author":"AJE Dirkzwager","year":"2007","journal-title":"BMC Fam Pract"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/1472-6963-13-520","article-title":"Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: a cross-sectional study on burden","volume":"13","author":"LN Zonneveld","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1192\/bjp.184.6.470","article-title":"Somatoform disorders in general practice: Prevalence, functional impairment and comorbidity with anxiety and depressive disorders","volume":"184","author":"MWM De Waal","year":"2004","journal-title":"Br J Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/PSY.0000000000000161","article-title":"Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: results from the LifeLines cohort study","volume":"77","author":"KAM Janssens","year":"2015","journal-title":"Psychosom Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.PSY.0000075977.90337.E7","article-title":"Medically unexplained physical symptoms, anxiety, and depression: A meta-analytic review","volume":"65","author":"P Henningsen","year":"2003","journal-title":"Psychosom Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archpsyc.62.8.903","article-title":"Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity","volume":"62","author":"AJ Barsky","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jpsychores.2013.08.011","article-title":"Association of costs with somatic symptom severity in patients with medically unexplained symptoms","volume":"75","author":"A Konnopka","year":"2013","journal-title":"J Psychosom Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000337349","article-title":"Economics of medically unexplained symptoms: a systematic review of the literature","volume":"81","author":"A Konnopka","year":"2012","journal-title":"Psychother Psychosom"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med"},{"key":"ref20","first-page":"CD011142","article-title":"Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults","volume":"11","author":"N van Dessel","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","article-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2015"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2016.12.005","article-title":"Cost-effectiveness of interventions for treating anxiety disorders: A systematic review","volume":"210","author":"RH Ophuis","year":"2017","journal-title":"J Affect Disord"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0266462305050324","article-title":"Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria","volume":"21","author":"S Evers","year":"2005","journal-title":"Int J Technol Assess Health Care"},{"key":"ref24","unstructured":"Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration, 2011. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/handbook.cochrane.org\" xlink:type=\"simple\">http:\/\/handbook.cochrane.org<\/ext-link>"},{"key":"ref25","unstructured":"Organisation for Economic Co-operation and Development (OECD). Purchasing power parities (PPP); 2018a. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm\" xlink:type=\"simple\">https:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm<\/ext-link> Cited 10 January 2018"},{"key":"ref26","unstructured":"Organisation for Economic Co-operation and Development (OECD). Monthly comparative price levels; 2018b. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/stats.oecd.org\/Index.aspx?DataSetCode=CPL\" xlink:type=\"simple\">http:\/\/stats.oecd.org\/Index.aspx?DataSetCode=CPL<\/ext-link> Cited 10 January 2018."},{"key":"ref27","article-title":"Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg","year":"2016"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1524-4733.2004.75003.x","article-title":"Use of cost- effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?","volume":"7","author":"HG Eichler","year":"2004","journal-title":"Value Health"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S0266462313000160","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"29","author":"D Husereau","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jpain.2017.03.001","article-title":"Cost-utility of group acceptance and commitment therapy for fibromyalgia versus recommended drugs: an economic analysis alongside a 6-month randomized controlled trial conducted in Spain (EFFIGACT Study)","volume":"18","author":"JV Luciano","year":"2017","journal-title":"J Pain"},{"key":"ref31","first-page":"811","article-title":"An analysis of panel data. The impact of a psychiatric consultation letter on the expenditures and outcomes of care for patients with somatization disorder","volume":"30","author":"TM Kashner","year":"1992","journal-title":"Med Care"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/archpsyc.1995.03950150070012","article-title":"A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients","volume":"52","author":"GR Smith Jr","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/fampra\/15.2.119","article-title":"Cost-effectiveness of a new treatment for somatized mental disorder taught to GPs","volume":"15","author":"R Morriss","year":"1998","journal-title":"Fam Pract"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3111\/13696998.2014.979291","article-title":"Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States","volume":"18","author":"H Huang","year":"2015","journal-title":"J Med Econ"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1524-4733.2007.00179.x","article-title":"Economic evaluation of tegaserod vs. placebo in the treatment of patients with irritable bowel syndrome: an analysis of the TENOR study","volume":"10","author":"A Bracco","year":"2007","journal-title":"Value Health"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s13075-014-0451-y","article-title":"Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic-evaluation alongside a 6-month randomized controlled trial","volume":"16","author":"JV Luciano","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/ar2377","article-title":"Cost-utility of an 8-month aquatic training for women with fibromyalgia: a randomized controlled trial","volume":"10","author":"N Gusi","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1472-6963-12-264","article-title":"Cost-effectiveness of counselling, graded-exercise and usual care for chronic fatigue: evidence from a randomised trial in primary care","volume":"12","author":"R Sabes-Figuera","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1017\/S0033291704001928","article-title":"Cost-effectiveness of cognitive behavioural therapy, graded exercise and usual care for patients with chronic fatigue in primary care","volume":"34","author":"P McCrone","year":"2004","journal-title":"Psychol Med"},{"key":"ref40","first-page":"15","article-title":"Chronic fatigue in general practice: Economic evaluation of counselling versus cognitive behaviour therapy","volume":"51","author":"D Chisholm","year":"2001","journal-title":"Br J Gen Pract"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3999(02)00397-5","article-title":"A controlled treatment study of somatoform disorders including analysis of healthcare utilization and Cost-effectiveness","volume":"54","author":"W Hiller","year":"2003","journal-title":"J Psychosom Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3111\/13696998.2011.586389","article-title":"Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States","volume":"14","author":"SM Beard","year":"2011","journal-title":"J Med Econ"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/gast.2003.50055","article-title":"The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome","volume":"124","author":"F Creed","year":"2003","journal-title":"Gastroenterology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2296-14-12","article-title":"Cost-effectiveness of supported self-management for CFS\/ME patients in primary care","volume":"14","author":"G Richardson","year":"2013","journal-title":"BMC Fam Pract"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/qjmed\/hch029","article-title":"Cost-effectiveness of cognitive behaviour therapy for patients with chronic fatigue syndrome","volume":"97","author":"JL Severens","year":"2004","journal-title":"QJM"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpsychores.2017.01.005","article-title":"Long-term economic evaluation of cognitive-behavioural group treatment versus enhanced usual care for functional somatic syndromes","volume":"94","author":"A Schr\u00f6der","year":"2017","journal-title":"J Psychosom Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1185\/03007991003600271","article-title":"Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective","volume":"26","author":"E Choy","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jval.2015.03.1791","article-title":"The cost-effectiveness of cognitive-behavioral group training for patients with unexplained physical symptoms","volume":"18","author":"MS Visser","year":"2015","journal-title":"Value Health"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s10198-015-0747-0","article-title":"Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland","volume":"17","author":"M Fisher","year":"2016","journal-title":"Eur J Health Econ"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1053\/j.gastro.2004.03.012","article-title":"Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis","volume":"126","author":"BM Spiegel","year":"2004","journal-title":"Gastroenterology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"O30","DOI":"10.1111\/codi.13149","article-title":"Cost-effectiveness analysis of sacral nerve stimulation as treatment for severe irritable bowel syndrome","volume":"18","author":"LS Tipsmark","year":"2016","journal-title":"Colorectal Dis"},{"key":"ref52","first-page":"120","article-title":"Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico","volume":"8","author":"H Arreola Ornelas","year":"2012","journal-title":"Reumatol Clin"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3111\/13696998.2012.660254","article-title":"The Cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective","volume":"15","author":"A Lloyd","year":"2012","journal-title":"J Med Econ"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpsychores.2016.09.001","article-title":"Cost-utility of a specific collaborative group intervention for patients with functional somatic syndromes","volume":"90","author":"A Konnopka","year":"2016","journal-title":"J Psychosom Res"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"e83894","DOI":"10.1371\/journal.pone.0083894","article-title":"Economic evaluation of brief psychodynamic interpersonal therapy in patients with multisomatoform disorder","volume":"9","author":"N Chernyak","year":"2014","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpsychores.2013.01.001","article-title":"Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: a Cost-effectiveness study","volume":"74","author":"H Van Ravesteijn","year":"2013","journal-title":"J Psychosom Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s11606-013-2392-6","article-title":"A randomized trial of treatments for high-utilizing somatizing patients","volume":"28","author":"AJ Barsky","year":"2013","journal-title":"J Gen Intern Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/AJP.0b013e318270f99a","article-title":"Cost-utility of a psychoeducational intervention in fibromyalgia patients compared with usual care: an economic evaluation alongside a 12-month randomized controlled trial","volume":"29","author":"JV Luciano","year":"2013","journal-title":"Clin J Pain"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/rheumatology\/kem157","article-title":"Cost-effectiveness of spa treatment for fibromyalgia: general health improvement is not for free","volume":"46","author":"TR Zijlstra","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"ref60","first-page":"1246","article-title":"Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. II Economic evaluation","volume":"23","author":"ME Goossens","year":"1996","journal-title":"J Rheumatol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1471-230X-12-149","article-title":"Cost-effectiveness of acupuncture for irritable bowel syndrome: findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care","volume":"12","author":"E Stamuli","year":"2012","journal-title":"BMC Gastroenterology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1471-2458-11-215","article-title":"Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial","volume":"11","author":"E Andersson","year":"2011","journal-title":"BMC Public Health"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-230X-11-110","article-title":"Acceptability, effectiveness, and Cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial","volume":"11","author":"B Ljotsson","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MEG.0b013e3282f2519d","article-title":"Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome","volume":"20","author":"P McCrone","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/gut.2004.062901","article-title":"A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome","volume":"55","author":"A Robinson","year":"2006","journal-title":"Gut"},{"issue":"6","key":"ref66","doi-asserted-by":"crossref","first-page":"e0177260","DOI":"10.1371\/journal.pone.0177260","article-title":"Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: A randomized controlled trial","volume":"12","author":"D Vos-Vromans","year":"2017","journal-title":"PLoS One"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12875-014-0184-7","article-title":"Cost-effectiveness of chronic fatigue self-management versus usual care: a pilot randomized controlled trial","volume":"15","author":"H Meng","year":"2014","journal-title":"BMC Fam Pract"},{"issue":"8","key":"ref68","doi-asserted-by":"crossref","first-page":"e40808","DOI":"10.1371\/journal.pone.0040808","article-title":"Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis","volume":"7","author":"P McCrone","year":"2012","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0205278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T17:18:05Z","timestamp":1589044685000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0205278"}},"subtitle":[],"editor":[{"given":"Stefan K.","family":"Lhachimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":68,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0205278","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]}}}